Default company panoramic image


We develop enzyme based treatment for alcohol and cocaine dependencies as well as a number of acute alcohol related orphan diseases.

  • Stage Concept Only
  • Industry Biotechnology
  • Location San Francisco, CA, USA
  • Currency USD
  • Founded October 2012
  • Website

Company Summary

We pursue development of safe and effective medical treatment for over 23mln people in the US and many more worldwide suffering from alcohol and drug dependence.


  • Default avatar
    Denis Kourakin

    Denis has had 15 years of experience in operations, investment management and management consulting across a number of industries including pharmaceuticals. As a consultant for the Boston Consulting Group, Denis developed product portfolio strategy in four European markets of the leading multinational pharmaceutical company. He also led a corporate finance task force in an integration project for two leading pharmaceutical companies in France and

  • Default avatar
    Ilana Katsnelson

    Dr. Katsnelson has eight years of experience in the pharmaceutical industry, as well as experience in different stages of drug development. In addition, Dr. Katsnelson has over 25 years of clinical practice experience in the U.S. and Latvia. Dr. Katsnelson was a medical monitor for multiple clinical trial projects in the U.S., Canada, and the EU. In her role, she was responsible for monitoring clinical studies from phase 1 to phase 3 in numerous